ProfileGDS4132 / 1565269_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 74% 55% 64% 63% 70% 61% 58% 74% 70% 74% 87% 82% 79% 80% 76% 80% 85% 43% 66% 82% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101228.30374
GSM201543Muscle PCOS pioglitazone 121142.47255
GSM201544Muscle PCOS pioglitazone 161186.41564
GSM201545Muscle PCOS pioglitazone 201189.22663
GSM201829Muscle PCOS pioglitazone 231220.98970
GSM201830Muscle PCOS pioglitazon 251177.86661
GSM201831Muscle PCOS pioglitazone 271165.858
GSM201832Muscle PCOS pioglitazone 31219.4174
GSM201833Muscle PCOS pioglitazone 41199.2470
GSM201834Muscle PCOS pioglitazone 81233.32574
GSM201835Muscle PCOS after pioglitazone 102383.80687
GSM201836Muscle PCOS after pioglitazone 122294.43782
GSM201837Muscle PCOS after pioglitazone 162253.71179
GSM201838Muscle PCOS after pioglitazone 202291.04680
GSM201839Muscle PCOS after pioglitazone 232251.8976
GSM201840Muscle PCOS after pioglitazone 252296.72980
GSM201841Muscle PCOS after pioglitazone 272329.62385
GSM201842Muscle PCOS after pioglitazone 3293.160643
GSM201843Muscle PCOS after pioglitazone 42183.76366
GSM201844Muscle PCOS after pioglitazone 82308.73682